Active Life Scientific, Inc. (ALSI) lero yalengeza kuti yalandira chilolezo cha US Food and Drug Administration De Novo chifukwa cha chipangizo chake choyezera mafupa. Kuwunika kwa Bone Score™ kumatenga njira yatsopano yoyezera fupa ndikugwiritsa ntchito ukadaulo waukadaulo kuyesa minofu yam'mafupa. Ikhoza kugwiritsidwa ntchito, pamodzi ndi mayesero ena ozindikira matenda, kuthandiza madokotala kusonkhanitsa kumvetsetsa kwakukulu kwa thanzi la mafupa a wodwala. Chilolezo chaposachedwa cha US chikutsatira CE Mark ku Europe (chomwe chinapezedwa mu 2017) ndipo chikuwonetsa gawo lofunikira pakukulitsa zida zopezeka kwa madokotala omwe amasamalira thanzi la mafupa.
“Pali kusiyana pakati pa kuchuluka kwa fupa limene muli nalo, kapena kusachulukira kwake, ndi mmene mafupa anu alili abwino, kapena kuti ndi abwino. Tsoka ilo, kuwunika kwachipatala kwaubwino kumakhalabe 'bokosi lakuda'. Mayeso a Bone Score ™ amawerengera momwe minofu ya mafupa imakanira zovuta zakuthupi, pamtunda wotetezeka, wa microscopic, ndipo imapereka deta yomwe sinapezekepo kale kuti madokotala aziganizira pofufuza ubwino wa fupa la wodwala, 'anawonjezera Dr. Hansma.
Kuwunika kotetezeka komanso kopanda ma radiation muofesi, Bone Score™, kumasiyanitsidwa ndi njira zina zama radiological kapena zojambula (X-ray, DEXA ndi CT) zomwe zimayesa kuchuluka kwa mafupa amchere ndi kapangidwe kake. Ndi njira yakuthupi, pogwiritsa ntchito chipangizo chamakono (OsteoProbe®), chomwe chimatchedwa Bone Material Strength index (BMSi) kapena Bone Score ™, ndipo imapatsa madokotala chidziwitso chomwe sichinapezeke chomwe angaganizire, pamodzi ndi zinthu zina, pamene kupenda thanzi la mafupa a wodwala.
ZOMWE MUNGACHITE PA NKHANIYI:
- It is a physical method, using a novel device (the OsteoProbe®), that is quantified as Bone Material Strength index (BMSi) or Bone Score™, and provides physicians with previously unavailable information that they can consider, along with other factors, when evaluating a patient’s bone health.
- The Bone Score™ test quantifies how bone tissue resists a physical challenge, on a safe, microscopic level, and provides previously unavailable data for physicians to consider when investigating the quality of a patient’s bone,' Dr.
- clearance follows CE Mark in Europe (obtained in 2017) and marks an important step in expanding tools available to physicians who manage bone health.
